Showing results (1-10 of 54) with videos related to
Sort By:
Pageof 6
Psychiatria Polska|July 30, 2013
[Pharmacological features of naltrexone and its use in the treatment of alcohol dependence]Przemysław BieńkowskiPsychiatria Polska|July 14, 2024
Efficacy and tolerability of brexpiprazole - a new antipsychotic drug from the group of dopamine D2 receptor partial agonistsPrzemysław Bieńkowski, Adam WichniakPsychiatria Polska|January 20, 2019
Cariprazine - a novel antipsychotic drug and its place in the treatment of schizophreniaBłażej Misiak, Przemysław Bieńkowski, Jerzy SamochowiecPsychiatria Polska|June 22, 2015
[Towards better non-selectivity: the role of 5-HT7 receptors in therapeutic efficacy of a second-generation antipsychotic - lurasidone]Przemysław Bieńkowski, Dominika Dudek, Jerzy SamochowiecPharmacological Reports : PR|June 7, 2014
Drinking of flavored solutions by high preferring (WHP) and low preferring (WLP) alcohol-drinking ratsWanda Dyr, Edyta Wyszogrodzka, Paweł Mierzejewski, et al.Journal of Psychiatric Research|December 19, 2025
Alexithymia among patients with obesity - systematic reviewMarta Cudzik, Martyna Lis, Adam Wichniak, et al.Psychiatria Polska|December 11, 2012
[Antidepressant effect of ketamine, a N-methyl-D-aspartate (NMDA) glutamate receptor antagonist, in the therapy of treatment-resistant depression]Paweł Gosek, Magdalena Chojnacka, Przemysław Bieńkowski, et al.Psychiatria Polska|June 21, 2014
[Effectiveness of ketamine in depressed patients resistant to ECT or rTMS therapy]Paweł Gosek, Magdalena Chojnacka, Przemysław Bieńkowski, et al.International Review of Psychiatry (Abingdon, England)|July 25, 2025
Mental healthcare and addiction services in Poland: a (hi)story of attraction and rejectionJustyna Klingemann, Przemysław Bieńkowski, Błażej Misiak, et al.Psychiatria Polska|April 30, 2017
Paliperidone palmitate: effectiveness, safety, and the use for treatment of schizophreniaMarek Jarema, Przemysław Bieńkowski, Janusz Heitzman, et al.Pageof 6